We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”

Learn more about it by watching THIS NOW.

Bradley J. Tandy net worth and biography

Bradley Tandy Biography and Net Worth

SVP of Enovis

Prior to joining the Enovis leadership team in 2019, Mr. Bradley Tandy served as Executive Vice President, General Counsel, and Secretary of DJO Global. Before DJO, Mr. Tandy was Senior Vice President, General Counsel, and Secretary of Biomet, Inc. from 2006 to 2014 and served as Vice President, Assistant General Counsel, and Chief Compliance Officer from 1999 to 2006. He joined Biomet as Assistant General Counsel in 1992. Previous to his employment at Biomet, he was a partner in the law firm of Rasor, Harris, Lemon, & Reed in Warsaw, Indiana, where he focused his practice on representation of medical device and healthcare companies. Mr. Tandy was an elected public official in Kosciusko County, Indiana, serving as a county councilman for 22 years. He received his undergraduate degree in political science from DePauw University and earned a Doctor of Jurisprudence degree from the Indiana University Maurer School of Law.

What is Bradley J. Tandy's net worth?: The estimated net worth of Bradley J. Tandy is at least $615,498.95 as of February 27th, 2023. Mr. Tandy owns 13,483 shares of Enovis stock worth more than $615,499 as of December 18th. This net worth evaluation does not reflect any other assets that Mr. Tandy may own. Learn More about Bradley J. Tandy's net worth.
How old is Bradley J. Tandy?: Mr. Tandy is currently 65 years old. There are 6 older executives and no younger executives at Enovis. Learn More on Bradley J. Tandy's age.
How do I contact Bradley J. Tandy?: The corporate mailing address for Mr. Tandy and other Enovis executives is 2711 Centerville Road Suite 400, Wilmington DE, 19808. Enovis can also be reached via phone at 302-252-9160 and via email at [email protected]. Learn More on Bradley J. Tandy's contact information.
Has Bradley J. Tandy been buying or selling shares of Enovis?: Bradley J. Tandy has not been actively trading shares of Enovis during the past quarter. Most recently, Bradley J. Tandy sold 2,491 shares of the business's stock in a transaction on Monday, February 27th. The shares were sold at an average price of $56.08, for a transaction totalling $139,695.28. Following the completion of the sale, the senior vice president now directly owns 13,483 shares of the company's stock, valued at $756,126.64. Learn More on Bradley J. Tandy's trading history.
Who are Enovis' active insiders?: Enovis' insider roster includes Benjamin Berry (CFO), Christopher Hix (CFO), John Kleckner (Insider), Patricia Lang (SVP), A. Perfall (Director), Daniel Pryor (EVP), Brady Shirley (COO), Bradley Tandy (SVP), Matthew Trerotola (CEO & Chairman), and Rajiv Vinnakota (Director). Learn More on Enovis' active insiders.

Bradley J. Tandy Insider Trading History at Enovis

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
2/27/2023	Sell	2,491	$56.08	$139,695.28	13,483
8/8/2022	Sell	3,355	$58.39	$195,898.45	13,845

Bradley J. Tandy Buying and Selling Activity at Enovis

Enovis Company Overview

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Today's Range

Now: $45.54

$45.54

$45.65

50 Day Range

MA: $44.38

$38.72

$49.33

2 Week Range

Now: $45.54

$38.27

$65.03

Volume

6,119 shs

Average Volume

576,830 shs

Market Capitalization

$2.54 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.94

The #1 Crypto for AI

From Weiss Ratings | Ad